U.S. Physical Therapy, Inc. (USPH)
- Previous Close
100.38 - Open
100.72 - Bid 94.96 x 1000
- Ask 103.16 x 1000
- Day's Range
100.54 - 101.18 - 52 Week Range
78.08 - 124.11 - Volume
30,485 - Avg. Volume
71,141 - Market Cap (intraday)
1.516B - Beta (5Y Monthly) 1.38
- PE Ratio (TTM)
78.60 - EPS (TTM)
1.28 - Earnings Date May 7, 2024
- Forward Dividend & Yield 1.76 (1.75%)
- Ex-Dividend Date Mar 11, 2024
- 1y Target Est
119.88
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
www.usph.com3,899
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: USPH
Performance Overview: USPH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USPH
Valuation Measures
Market Cap
1.52B
Enterprise Value
1.62B
Trailing P/E
78.60
Forward P/E
39.22
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.36
Price/Book (mrq)
3.18
Enterprise Value/Revenue
2.68
Enterprise Value/EBITDA
21.81
Financial Highlights
Profitability and Income Statement
Profit Margin
4.72%
Return on Assets (ttm)
4.69%
Return on Equity (ttm)
6.55%
Revenue (ttm)
598.63M
Net Income Avi to Common (ttm)
18.14M
Diluted EPS (ttm)
1.28
Balance Sheet and Cash Flow
Total Cash (mrq)
155.49M
Total Debt/Equity (mrq)
39.65%
Levered Free Cash Flow (ttm)
65.97M
Research Analysis: USPH
Company Insights: USPH
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: USPH
USPH: Raising target price to $83.00
U.S. PHYSICAL THERAPY INC has an Investment Rating of SELL; a target price of $83.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetUSPH: Lowering target price to $79.00
U.S. PHYSICAL THERAPY INC has an Investment Rating of SELL; a target price of $79.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetUSPH: Lowering target price to $85.00
U.S. PHYSICAL THERAPY INC has an Investment Rating of SELL; a target price of $85.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetUSPH: Lowering target price to $86.00
U.S. PHYSICAL THERAPY INC has an Investment Rating of SELL; a target price of $86.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target